Comparative in silico Survey of Retinoic Acids as Putative Biomolecules Against VEGF Receptors: A Glycomics-based Approach

A. Fallah, Esmaeil Samadian, Azadeh Mohammad-Hasani, A. Colagar
{"title":"Comparative in silico Survey of Retinoic Acids as Putative Biomolecules Against VEGF Receptors: A Glycomics-based Approach","authors":"A. Fallah, Esmaeil Samadian, Azadeh Mohammad-Hasani, A. Colagar","doi":"10.22067/JCMR.V12I2.89670","DOIUrl":null,"url":null,"abstract":"In this study, putative interactions between all of the retinoic acid (RA) ligands (all-trans (At), 9-cis (9c), and 13-cis (13c)), and VEGF receptors (VEGFR-1, -2 and -3) were investigated. It was performed considering the glycosylation status of the receptors to achieve a more reliable mode of interactions based on glycomics. We found that RAs may have a higher affinity for ligand-binding domains in VEGFRs. Furthermore, all RA isomers can strongly attach to VEGFR-3 receptor in comparison to other ones. It was also demonstrated that receptor dimerization of RAs may be less targeted. Moreover, regarding post-translational modifications, glycosylated structures showed conflicting binding energies. RAs may target the human vasculature, specifically lymph vessels, through VEGFR-3. In addition, the ligand binding-mediated activation of VEGFRs may be affected by these agents. Also, the glycosylation status of the receptors can interfere with these manners. Furthermore, our results confirmed that the consideration of carbohydrates in crystal structures is essential for a better interpretation of ligand/receptor interactions during drug discovery studies. Even though these observations improved our understanding of the binding patterns of RAs to VEGFRs, validation of these results needs further analysis to introduce these biomolecules as anti-VEGF remedies.","PeriodicalId":30607,"journal":{"name":"Journal of Cell and Molecular Research","volume":"12 1","pages":"87-96"},"PeriodicalIF":0.0000,"publicationDate":"2021-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cell and Molecular Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22067/JCMR.V12I2.89670","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In this study, putative interactions between all of the retinoic acid (RA) ligands (all-trans (At), 9-cis (9c), and 13-cis (13c)), and VEGF receptors (VEGFR-1, -2 and -3) were investigated. It was performed considering the glycosylation status of the receptors to achieve a more reliable mode of interactions based on glycomics. We found that RAs may have a higher affinity for ligand-binding domains in VEGFRs. Furthermore, all RA isomers can strongly attach to VEGFR-3 receptor in comparison to other ones. It was also demonstrated that receptor dimerization of RAs may be less targeted. Moreover, regarding post-translational modifications, glycosylated structures showed conflicting binding energies. RAs may target the human vasculature, specifically lymph vessels, through VEGFR-3. In addition, the ligand binding-mediated activation of VEGFRs may be affected by these agents. Also, the glycosylation status of the receptors can interfere with these manners. Furthermore, our results confirmed that the consideration of carbohydrates in crystal structures is essential for a better interpretation of ligand/receptor interactions during drug discovery studies. Even though these observations improved our understanding of the binding patterns of RAs to VEGFRs, validation of these results needs further analysis to introduce these biomolecules as anti-VEGF remedies.
视黄酸作为抗VEGF受体的推定生物分子的计算机对比研究:基于糖组学的方法
在本研究中,研究了所有维甲酸(RA)配体(全反式(At)、9-顺式(9c)和13-顺式(13c))与VEGF受体(VEGFR-1、-2和-3)之间的假定相互作用。它是在考虑受体的糖基化状态的情况下进行的,以实现基于糖组学的更可靠的相互作用模式。我们发现RA可能对VEGFR中的配体结合结构域具有更高的亲和力。此外,与其他异构体相比,所有RA异构体都能强烈附着在VEGFR-3受体上。研究还表明,RA的受体二聚化可能不太具有靶向性。此外,关于翻译后修饰,糖基化结构显示出相互冲突的结合能。RA可以通过VEGFR-3靶向人类血管系统,特别是淋巴血管。此外,配体结合介导的VEGFR活化可能受到这些试剂的影响。此外,受体的糖基化状态可能干扰这些方式。此外,我们的研究结果证实,在药物发现研究中,考虑晶体结构中的碳水化合物对于更好地解释配体/受体相互作用至关重要。尽管这些观察结果提高了我们对RA与VEGFR结合模式的理解,但这些结果的验证需要进一步分析,以引入这些生物分子作为抗VEGF药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
1
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书